In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.
AstraZeneca’s Rebekah Martin on diversity and inclusion: the pharmaphorum podcast
The Alderley Park Discovery Podcast: Life science skills, staffing and support
J&J and medical device innovation: the pharmaphorum podcast
Biotech trends in COVID era: the pharmaphorum podcast
GSK and eosinophil research: the pharmaphorum podcast
Gitte Aabo on telemedicine and her time at LEO Pharma: the pharmaphorum podcast
The Alderley Park Discovery Podcast: COVID testing and the Lighthouse Lab
Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast
Novartis, company culture and COVID-19: the pharmaphorum podcast
Amgen and science education: the pharmaphorum podcast
UK pharma leadership and COVID-19: the pharmaphorum podcast
Eisai and Alexa skills in epilepsy: the pharmaphorum podcast
Digital health and interoperability: the pharmaphorum podcast
Roche, big data and patient outcomes: the pharmaphorum podcast
Pfizer and the UK cancer landscape: the pharmaphorum podcast
Life sciences leadership: the pharmaphorum podcast
AstraZeneca and lung cancer: the pharmaphorum podcast
Lung cancer’s patient information gap: the pharmaphorum podcast
The state of UK drug discovery: the pharmaphorum podcast
Addressing global health challenges: the pharmaphorum podcast
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Speaking of Psychology